WOCKPHARMA - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 2.3
Show all parameters (20 more)
🧾 Chart Verdict
Entry Zone: A short-term entry could be considered around 2,140 - 2,165, utilizing the immediate support levels. An exit zone would be established at 2,300 – 2,350, targeting the recent high and a potential resistance level. Overall, while the momentum is positive, the elevated valuation warrants caution. A close below 2,120 would trigger a review of the short-term outlook.
✅ Positive
The stock is currently trading above its 200-day moving average, suggesting a prevailing uptrend momentum. Volume remains elevated compared to the weekly average, reinforcing this upward movement and indicating strong buying interest. We are seeing confluent support around the 1952 level (DMA 50) coinciding with the 1694 level (DMA 200), which could provide stability.
⚠️ Limitation
The extremely high P/E ratio of 107, significantly above the industry average of 34.6, indicates the stock is potentially overvalued relative to its peers and reliant on future growth assumptions. This premium valuation makes it susceptible to a correction if market sentiment shifts or earnings expectations are not met. Furthermore, the relatively low dividend yield (0.00%) doesn't provide any immediate upside for investors seeking income.
📉 Company Negative News
Recent news reports highlight five straight sessions of gains for Wockhardt shares, driven by CNBC TV18 and Business Standard, suggesting continued positive momentum within the industry.
🏭 Industry
The pharmaceutical sector is currently experiencing moderate growth due to increasing healthcare expenditure and generic drug demand. However, intense competition among players and regulatory scrutiny remain significant risks for companies like Wockhardt. Sector PE ratios are typically higher than average reflecting potential future growth prospects.